Search

Your search keyword '"Perales C"' showing total 100 results

Search Constraints

Start Over You searched for: Author "Perales C" Remove constraint Author: "Perales C" Database Unpaywall Remove constraint Database: Unpaywall
100 results on '"Perales C"'

Search Results

4. PO.3.61 Renal involvement and cardiovascular risk in systemic lupus erythematosus patients

5. PO.5.116 Lupus nephritis response in terms of kidney function, urine sediment and serological activity after belimumab treatment

6. PO.3.66 TLR9 protein level is associated to proinflammatory cytokine level of IL10 and inf1a in SLE patients

7. PO.8.175 Antimalarial drugs and electrocardiographic alterations in patients with systemic lupus erythematosus

8. AB0534 PROSPECTIVE STUDY OF 24 MONTHS OF EVOLUTION OF A COHORT OF PATIENTS WITH RHUPUS

9. AB0327 CARDIOVASCULAR RISK ASSESSMENT IN RHEUMATOID ARTHRITIS WITH CAROTID ULTRASONOGRAPHY AND CARDIOVASCULAR RISK SCORES: A CASE CONTROL STUDY

10. AB0435 LUPUS NEPHRITIS RESPONSE IN TERMS OF KIDNEY FUNCTION, URINE SEDIMENT AND SEROLOGICAL ACTIVITY AFTER SUBCUTANEOUS BELIMUMAB TREATMENT

11. POS0544 REMOTE MONITORING TOOLS IN RA PATIENTS: FACIT-FATIGUE AND HAQ

12. AB0324 SAFETY PROFILE OF JAK INHIBITORS IN REAL WORLD FROM A SINGLE CENTER COHORT

13. AB0411 IMPACT OF GENDER IN JAK INHIBITORS PRESCRIPTION: ANALYSIS FROM A SINGLE CENTER COHORT

14. AB1168 CLINICAL AND SEROLOGICAL EVOLUTION OF RHEUMATIC PATIENTS INFECTED BY SARS-COV-2

15. POS0191 ANTIMALARIAL DRUGS AND ELECTROCARDIOGRAPHIC ALTERATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.

16. AB1316 PREVALENCE, DIAGNOSTIC DELAY AND TREATMENT PROFILE OF PATIENTS WITH MONOGENIC AUTOINFLAMMATORY DISEASES IN AN ADULT RHEUMATOLOGY SERVICE OF A TERTIARY HOSPITAL.

17. AB0233 CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS: A TWO YEARS OBSERVATIONAL STUDY.

18. AB1024 SECONDARY PREVENTION OF VERTEBRAL FRACTURES SUSTAINED EFFICACY OVER TIME

19. AB1256 TRANSITIONAL CARE IN JUVENILE IDIOPATHIC ARTHRITIS: TIMING, PREVALENCE OF SUBTYPES AND TREATMENT PROFILE IN A SPANISH TERTIARY HOSPITAL.

20. POS0067 PULMONARY FUNCTION IN PATIENTS DIAGNOSED OF EARLY SYSTEMIC SCLEROSIS: 10 YEARS EXPERIENCE.

23. POS1365 ANNALYSIS OF PRO-INFLAMMATORY BIOMARKERS IN A POLYMYALGIA RHEUMATICA COHORT DURING THE ACUTE ONSET OF THE DISEASE

24. POS1157 CONCORDANCE BETWEEN THE QUANTIFERON-TB GOLD IN-TUBE AND TUBERCULIN TEST FOR THE DIAGNOSIS OF LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH RHEUMATIC DISEASES

25. AB0502 HEALTH-RELATED QUALITY OF LIFE MEASURES IN SPONDYLOARTHROPATY PATIENTS UNDER BIOLOGICAL THERAPIES IN REAL LIFE

26. POS0167 SECONDARY PREVENTION OF VERTEBRAL FRACTURES IN REAL PRACTICE

28. Efecto de la inclusión de diferentes niveles de probiótico sobre los parámetros productivos y morfología intestinal en cuyes de engorde (Cavia porcellus)

30. AB1066 EFFICACY AND SAFETY OF APREMILAST IN BEHÇET DISEASE PATIENTS

31. AB0165 THE ROLE OF CXCL4, CXCL8 AND GDF-15 IN SYSTEMIC SCLEROSIS

32. AB1048 RHUPUS SYNDROME IN A TERTIARY HOSPITAL

33. SAT0077 CARDIOVASCULAR RISK ASSESSMENT WITH CAROTID ULTRASONOGRAPHY IN ADDITION TO THE TRADITIONAL CARDIOVASCULAR RISK FACTORS IN RHEUMATOID ARTHRITIS PATIENTS: A CASE CONTROL STUDY

34. FRI0437 CT GUIDED NEEDLE BIOPSY IN VERTEBRAL OSTEOMYELITIS: RELIABILITY ANALYSIS AND STUDY OF WHICH FACTORS COULD INFLUENCE ON THE RESULT

35. AB0597 PULMONARY FUNCTION IN PATIENTS DIAGNOSED OF EARLY SYSTEMIC SCLEROSIS: A NEW TOOL FOR SYSTEMIC SCLEROSIS CLASIFFICATION?

36. FRI0124 EFFICACY AND SAFETY OF BARICITINIB AND TOFACITINIB IN RHEUMATOID ARTHRITIS: DATA FROM REAL-WORLD

43. High HCV subtype heterogeneity in a chronically infected general population revealed by high-resolution hepatitis C virus subtyping

47. Allelic variantes of Aurora B kinase gene can be related with fibrosis progression in chronic hepatitis C

48. Viral load at 15 days after liver transplantation as a good predictor of fast liver fibrosis progression

49. Hepatitis C virus early kinetics and resistance-associated substitution dynamics during antiviral therapy with direct-acting antivirals

50. Molecular characterization of Hepatitis C virus resistance-associated substitutions after interferon-free treatment failure by massive parallel sequencing

Catalog

Books, media, physical & digital resources